| Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice J Ramos da Silva, K Bitencourt Rodrigues, G Formoso Pelegrin, ... Science Translational Medicine 15 (686), eabn3464, 2023 | 43 | 2023 |
| Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice JR Silva, KB Rodrigues, GF Pelegrin, NS Sales, H Muramatsu, MO Silva, ... Science Translational Medicine 15 (686), 1-18, 2023 | 10 | 2023 |
| Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus MTP Favaro, MJ Rodrigues-Jesus, AA Venceslau-Carvalho, RPDS Alves, ... Nanomedicine: Nanotechnology, Biology and Medicine 32, 102334, 2021 | 10 | 2021 |
| A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model J Ramos da Silva, AC Ramos Moreno, N Silva Sales, M de Oliveira Silva, ... Oncoimmunology 10 (1), 1949896, 2021 | 9 | 2021 |
| Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies AA Venceslau-Carvalho, MT de Pinho Favaro, LR Pereira, ... Nanomedicine: Nanotechnology, Biology and Medicine 37, 102445, 2021 | 6 | 2021 |
| Transcutaneous administration of dengue vaccines R Andreata-Santos, RPS Alves, SA Pereira, LR Pereira, CL Freitas, ... Viruses 12 (5), 514, 2020 | 4 | 2020 |
| Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation MJ Rodrigues-Jesus, MT de Pinho Favaro, AA Venceslau-Carvalho, ... Nanomedicine: Nanotechnology, Biology and Medicine 45, 102595, 2022 | 3 | 2022 |
| The Anti-Dengue Virus Peptide DV2 Inhibits Zika Virus Both In Vitro and In Vivo MF Castro-Amarante, SS Pereira, LR Pereira, LS Santos, ... Viruses 15 (4), 839, 2023 | 2 | 2023 |
| Enhanced immune responses and protective immunity to zika virus induced by a DNA vaccine encoding a chimeric NS1 fused with type 1 Herpes Virus gD Protein LR Pereira, RPS Alves, NS Sales, R Andreata-Santos, ... Frontiers in Medical Technology 2, 604160, 2020 | 2 | 2020 |
| Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis PC Mota, ML Soares, AC Ferreira, RF Santos, JC Rufo, D Vasconcelos, ... Pulmonology, 2024 | 1 | 2024 |
| Corrigendum: Protective Immunity to Dengue Virus Induced by DNA Vaccines Encoding Nonstructural Proteins in a Lethal Challenge Immunocompetent Mouse Model RPS Alves, R Andreata-Santos, CL de Freitas, LR Pereira, ... Frontiers in Medical Technology 2, 626114, 2020 | 1 | 2020 |
| Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein MO Silva, MF Castro-Amarante, AA Venceslau-Carvalho, BS Almeida, ... Vaccines 12 (4), 356, 2024 | | 2024 |
| Layer-by-Layer Assembly of Polymeric Nanoparticles with Heparin-RBD Complexes as an Adjuvant for SARS-CoV-2 Protein-Based Vaccines G Delechiave, M de Oliveira Silva, MF de Castro-Amarante, ... ACS Applied Nano Materials, 2024 | | 2024 |
| Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses SS Pereira, R Andreata-Santos, MF de Castro-Amarante, ... Viruses 15 (9), 1936, 2023 | | 2023 |
| The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo MFC Amarante, SS Pereira, LR Pereira, LS Santos, AAV Carvalho, ... Viruses 15 (4), 1-11, 2023 | | 2023 |
| Nanovaccines against SARS-COV-2: how the incorporation of different categories of nanoparticles to a subunit vaccine affects the quality more than the quantity of induced … MTP Favaro, MJR Jesus, NC Dalibera, LS Rego, MFC Amarante, ... Anais, 2022 | | 2022 |
| Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation MJR Jesus, MTP Favaro, AAVB Carvalho, MFC Amarante, BS Almeida, ... Nanomedicine: Nanotechnology, Biology and Medicine 45, 1-11, 2022 | | 2022 |
| A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model JR Silva, ACR Moreno, NS Sales, MO Silva, LRMM Aps, BFMMP Ribeiro, ... OncoImmunology 10 (1), 1-13, 2021 | | 2021 |
| Transcutaneous administration of dengue vaccines RA Santos, RPS Alves, SA Pereira, LR Pereira, CL Freitas, SS Pereira, ... Viruses 12 (5), 16, 2020 | | 2020 |
| Enhanced immune responses and protective immunity to Zika vrus induced by a DNA vaccine encoding a chimeric NS1 fused wth tpe 1 Herpes vrus gD protein LR Pereira, RPS Alves, NS Sales, RA Santos, AAV Carvalho, SS Pereira, ... Frontiers in Medical Technology 2, 1-14, 2020 | | 2020 |
